References

Helicobacter pylori infection

10.1038/s41572-023-00431-8 · 2023 · External reference

Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial

10.1038/s41591-024-03153-w · 2024 · External reference

Evolving Concepts in Helicobacter pylori Management

10.1053/j.gastro.2023.09.047 · 2024 · External reference

Research progress of potassium-competitive acid blockers in the treatment of Helicobacter pylori

10.1080/07853890.2025.2544886 · 2025 · External reference

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

10.14309/ajg.0000000000002968 · 2024 · External reference

Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

10.1136/gutjnl-2022-327745 · 2022 · External reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

10.7326/0003-4819-147-8-200710160-00010 · 2007 · External reference

A Review in Helicobacter pylori Infection

10.1007/s40265-023-01991-5 · 2024 · External reference

Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors for First-Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta-Analysis

10.1111/hel.13150 · 2024 · External reference

Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

10.1007/s10620-024-08460-3 · 2024 · External reference

Seven-Day Versus 14-Day Tegoprazan and Tetracycline-Containing Quadruple Therapy for First-Line Eradication of Helicobacter pylori Infection: A Randomized, Open-Label

2025 · External reference

Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication

10.1111/hel.12953 · 2023 · External reference

Su1476: OPTIMIZING H. PYLORI ERADICATION IN OBESE PATIENTS: THE IMPACT OF WEIGHT-ADJUSTED QUADRUPLE THERAPY

10.1016/s0016-5085(25)02725-8 · 2025 · External reference

2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment

10.1097/cm9.0000000000002546 · 2022 · External reference

Antibiotic resistance of Helicobacter pylori in Mainland China: A focus on geographic differences through systematic review and meta-analysis

10.1016/j.ijantimicag.2024.107325 · 2024 · External reference

Antibiotic Combinations in Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta-Analysis

10.1111/hel.70101 · 2025 · External reference

Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study

10.1016/j.lanmic.2025.101217 · 2026 · External reference

Optimal therapy for Helicobacter pylori infections

10.1038/nrgastro.2010.210 · 2011 · External reference

Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management

10.1002/ueg2.12569 · 2024 · External reference

Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial

10.1111/hel.70056 · 2025 · External reference